Theme:
Light Dark Auto
GeneralTop StoriesPoliticsBusinessEconomyTechnologyInternationalEnvironmentScienceSportsHealthEducationEntertainmentLifestyleCultureCrime & LawTravel & TourismFood & RecipesFact CheckReligion
POLITICS
Neutral Sentiment

Federal Rescheduling Moves Marijuana to Schedule III

Read, Watch or Listen

Media Bias Meter
Sources: 11
Center 73%
Right 27%
Sources: 11

Washington, President Trump signed an executive order Thursday that reclassifies marijuana from Schedule I to Schedule III, directing the Justice Department and DEA to implement the change and opening federal avenues for medical research, potential tax adjustments for licensed businesses, and expanded banking access; states retain their own marijuana laws. Officials said the order acknowledges medical use but does not legalize recreational use nationwide. Industry groups, veteran advocates and state regulators responded this week with statements on anticipated impacts and next steps as federal agencies begin review, and congressional oversight reviews continue. Based on 11 articles reviewed and supporting research.

Prepared by Lauren Mitchell and reviewed by editorial team.

Timeline of Events

  • 1970: Controlled Substances Act places cannabis in Schedule I.
  • 2012: Colorado and Washington legalize recreational cannabis, triggering market growth.
  • Earlier administration: DOJ previously proposed moving cannabis to Schedule III.
  • This week: President Trump signed an executive order recommending rescheduling to Schedule III.
  • November 2025: Michigan reports nearly $2.9 billion in cannabis sales and record-low ounce prices.
Media Bias
Articles Published:
11
Right Leaning:
3
Left Leaning:
0
Neutral:
8

Who Benefited

Federal rescheduling could benefit medical researchers, licensed cannabis businesses, patients seeking medical access, banks considering cannabis clients, and investors by potentially easing research barriers, reducing tax burdens, and expanding financial services access contingent on DEA and Justice Department implementation.

Who Impacted

Opponents of legalization may see policy shifts; some small producers could face pricing pressure as Michigan retail prices have fallen, and individuals relying on state-level restrictions may encounter changing regulatory frameworks while federal illegality for some offenses persists until statutory changes occur.

Media Bias
Articles Published:
11
Right Leaning:
3
Left Leaning:
0
Neutral:
8
Distribution:
Left 0%, Center 73%, Right 27%
Who Benefited

Federal rescheduling could benefit medical researchers, licensed cannabis businesses, patients seeking medical access, banks considering cannabis clients, and investors by potentially easing research barriers, reducing tax burdens, and expanding financial services access contingent on DEA and Justice Department implementation.

Who Impacted

Opponents of legalization may see policy shifts; some small producers could face pricing pressure as Michigan retail prices have fallen, and individuals relying on state-level restrictions may encounter changing regulatory frameworks while federal illegality for some offenses persists until statutory changes occur.

Coverage of Story:

From Left

No left-leaning sources found for this story.

From Right

Trump set to deliver pot reform dream -- but rescheduling stops...

New York Post Boston Herald FOX 55 Fort Wayne

Related News

Comments

JQJO App
Get JQJO App
Read news faster on our app
GET